The journey to zero deep-vein thrombosis in critically ill patients.

Ann Thorac Med

Department of Intensive Care, Ministry of National Guard Health Affairs, Riyadh, Kingdom of Saudi Arabia.

Published: January 2019

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6784439PMC
http://dx.doi.org/10.4103/atm.ATM_179_19DOI Listing

Publication Analysis

Top Keywords

journey deep-vein
4
deep-vein thrombosis
4
thrombosis critically
4
critically ill
4
ill patients
4
journey
1
thrombosis
1
critically
1
ill
1
patients
1

Similar Publications

Multidisciplinary Approach to Venous Disease: Enhancing Patient Care and Trainee Education Through Collaboration.

Tech Vasc Interv Radiol

June 2023

Division of Vascular Surgery and Endovascular Surgery, Department of Surgery, University Hospitals Cleveland Medical Center, Cleveland OH. Electronic address:

The full spectrum of venous disease poses a significant burden on individuals and health-care systems globally. Venous disease can lead to a wide range of symptoms based on the level of disease and underlying pathology. In general, underlying pathologies are due to nonthrombotic (reflux/obstructive) and thrombotic causes.

View Article and Find Full Text PDF

Purpose: Prolongation of operation time due to registration and pin insertion has been reported with robotic-assisted total knee arthroplasty (RATKA), and there has been concern about an increase in the postoperative incidence of deep vein thrombosis (DVT). In this study, we compared the incidence of DVT after RATKA with that after conventional manual TKA (mTKA).

Methods: This consecutive retrospective series included 141 knees that underwent primary TKA using the Journey II system.

View Article and Find Full Text PDF

Has Lockdown and COVID-19 Led to a Change in the Characteristics of Deep Vein Thrombosis and Patients Who Are Afflicted With It?

Cureus

December 2022

Vascular Surgery, Northern Care Alliance NHS (National Health Service) Foundation Trust, Manchester, GBR.

Background: There is growing evidence identifying coronavirus disease 2019 (COVID-19) as a significant risk factor for thrombosis in inpatients. However, it remains uncertain if patients in the community have been influenced during the COVID-19 pandemic and national lockdown. This study, across four centres in the United Kingdom (UK), reviewed outpatients with deep vein thrombosis (DVT).

View Article and Find Full Text PDF

Hughes-Stovin syndrome (HSS) is a rare disease characterized by deep vein thrombosis and pulmonary and/or bronchial artery aneurysms. A 28-year-old female patient was followed-up for 5 months with pulmonary embolism. When she presented with hemoptysis at her 5th month, pulmonary artery aneurysm was detected on thoracic CT angiography.

View Article and Find Full Text PDF

Microbial Modulation of Coagulation Disorders in Venous Thromboembolism.

J Inflamm Res

July 2020

Department of Pharmaceutical Microbiology and Microbiological Diagnostics, Faculty of Pharmacy, Medical University of Lodz, Lodz, Poland.

Venous thromboembolism (VTE), including deep vein thrombosis (DVT) and pulmonary embolism (PE), is the third leading cause of cardiovascular death in the world. Important risk factors of thrombosis include bed restraint, surgery, major trauma, long journeys, inflammation, pregnancy, and oral contraceptives, previous venous thromboembolism, cancer, and bacterial infections. Sepsis increases the risk of blood clot formation 2-20 times.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!